Population
Endothelial cells
Design
Preclinical
Authors
Loading...
Supports Ang II-oxidative pathways in atherogenesis; extends mechanistic data but leaves open in vivo and clinical relevance.
Angiotensin II promotes early atherogenic changes in endothelial cells by inducing intracellular oxidative stress and upregulating VCAM-1 via NF-kappaB.
Pueyo et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: